We are live on
!
Find out more
B
Barings Portfolio holdings
AUM
$6.19B
1-Year Est. Return
16.5%
This Fund
S&P 500
This Quarter
Est. Return
+8.46%
1 Year Est. Return
+16.5%
3 Year Est. Return
+50.95%
5 Year Est. Return
+53.21%
10 Year Est. Return
+287.68%
AUM
$2.4B
AUM Growth
+$64.5M
(+2.8%)
Cap. Flow
-$473M
Cap. Flow
% of AUM
-19.74%
Top 10 Holdings %
Top 10 Hldgs %
19.06%
Holding
1,040
New
104
Increased
254
Reduced
395
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
USG
Usg
USG
|
+$7.82M |
| 2 |
Intel
INTC
|
+$5.57M |
| 3 |
HSH
HILLSHIRE BRANDS CO
HSH
|
+$4.9M |
| 4 |
Occidental Petroleum
OXY
|
+$4.62M |
| 5 |
DD
Du Pont De Nemours E I
DD
|
+$4.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HI
Hillenbrand
HI
|
+$9.91M |
| 2 |
Integra LifeSciences
IART
|
+$9.52M |
| 3 |
Bank of America
BAC
|
+$8.38M |
| 4 |
Columbus McKinnon
CMCO
|
+$7.4M |
| 5 |
ALR
Alere Inc
ALR
|
+$7.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.05% |
| 2 | Industrials | 10.4% |
| 3 | Healthcare | 9.34% |
| 4 | Consumer Discretionary | 8.65% |
| 5 | Energy | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QRE
826
DELISTED
QR ENERGY LP UNIT LTD PARTNERSHIP INT (DE)
QRE
| $214K | 0.01% |
12,500
-7,300
| -37% | -$123K |
|
827
iShares MSCI United Kingdom ETF
EWU
$4.1B
| $213K | 0.01% |
5,100
-1,450
| -22% | -$58.4K |
|
828
Universal Corp
UVV
$1.37B
| $213K | 0.01% |
3,900
-600
| -13% | -$31.2K |
|
829
Ralph Lauren
RL
$22.4B
| $212K | 0.01% |
1,200
-1,410
| -54% | -$240K |
|
830
Usana Health Sciences
USNA
$419M
| $212K | 0.01% |
5,600
-4,600
| -45% | -$176K |
|
831
Commerce Bancshares
CBSH
$8.68B
| $210K | 0.01% |
+8,408
| New | +$206K |
|
832
Hormel Foods
HRL
$14.2B
| $210K | 0.01% |
9,320
-16,600
| -64% | -$364K |
|
833
Primerica
PRI
$10.1B
| $210K | 0.01% |
+4,900
| New | +$208K |
|
|
GNC
834
DELISTED
GNC Holdings, Inc.
GNC
| $210K | 0.01% |
+3,600
| New | +$208K |
|
|
RSO
835
DELISTED
Resource Capital Corp.
RSO
| $208K | 0.01% |
8,750
| – | – |
|
836
Argan
AGX
$6.9B
| $207K | 0.01% |
+7,500
| New | +$175K |
|
837
Charles River Laboratories
CRL
$11.3B
| $207K | 0.01% |
+3,900
| New | +$196K |
|
838
Medifast
MED
$107M
| $206K | 0.01% |
7,900
| – | – |
|
|
JCP
839
DELISTED
J.C. Penney Company, Inc.
JCP
| $206K | 0.01% |
22,525
-26,700
| -54% | -$223K |
|
|
FINL
840
DELISTED
Finish Line
FINL
| $206K | 0.01% |
+7,300
| New | +$186K |
|
841
Sociedad Química y Minera de Chile
SQM
$19.3B
| $205K | 0.01% |
8,134
-9,941
| -55% | -$257K |
|
|
ECHO
842
EchoStar
ECHO
$24.3B
| $204K | 0.01% |
5,059
-833
| -14% | -$32.6K |
|
843
Simon Property Group
SPG
$76.4B
| $204K | 0.01% |
1,422
-4,518
| -76% | -$651K |
|
|
SBNY
844
DELISTED
Signature Bank
SBNY
| $204K | 0.01% |
+1,900
| New | +$194K |
|
845
Pediatrix Medical
MD
$2.2B
| $203K | 0.01% |
+3,800
| New | +$204K |
|
846
Domino's
DPZ
$11.9B
| $202K | 0.01% |
2,900
-4,600
| -61% | -$315K |
|
847
W.W. Grainger
GWW
$64.2B
| $201K | 0.01% |
786
-2,820
| -78% | -$733K |
|
|
OPLN
848
Openlane
OPLN
$4.28B
| $201K | 0.01% |
+17,966
| New | +$195K |
|
|
HCBK
849
DELISTED
HUDSON CITY BANCORP INC
HCBK
| $201K | 0.01% |
21,315
| – | – |
|
|
EFII
850
DELISTED
Electronics for Imaging
EFII
| $201K | 0.01% |
+5,200
| New | +$189K |
|
Similar funds
WIA
NP
LBA
EIP
ACM
AWA
DTC
CA
Barings's Q4 2013 Portfolio in Review
As of Q4 2013, Barings held 1,040 positions worth $2.4B, up 2.8% from $2.33B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Barings withdrew a net $473M in Q4 2013, closing 121 positions and reducing 395 holdings. Its most notable exit was Hillenbrand, an estimated $9.91M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Barings opened a new position in Usg worth $8.19M.
- Barings's largest Q4 2013 buy was Usg: 288,700 shares worth $8.19M.
- Barings added most to Intel in Q4 2013, an estimated $5.57M increase.
- Barings's biggest Q4 2013 reduction was Integra LifeSciences, cutting an estimated $9.52M.
- Barings fully exited Hillenbrand in Q4 2013, selling an estimated $9.91M.
- Barings's ten largest holdings make up 19% of its $2.4B portfolio in Q4 2013.
- Barings opened 104 new positions and closed 121 in Q4 2013.
- Barings's portfolio value rose 2.8% quarter-over-quarter to $2.4B.
Based on Barings's 13F filing for Q4 2013, filed 14 Feb 2014.